This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Aleutian Mink Disease Parvovirus VP2 (AMDV VP2)
Product Overview
BioVenic's Recombinant Aleutian Mink Disease Parvovirus VP2 (AMDV VP2) is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 24.9 kDa. It can be used for antibody production or for immunoassays.
Specifications
Target Information
Aleutian disease, caused by a parvovirus, was initially identified in mink during the 1940s. The disease is prevalent among both farmed and wild mink populations globally. The Aleutian disease virus (ADV) includes two capsid proteins, VP1 (85 kDa) and VP2 (75 kDa), both of which are translated from the same mRNA. The VP2 protein, being the principal capsid component, is capable of self-assembling into native-like capsids even in the absence of VP1.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in distilled water 1:100 as stock solution. Aliquote the reconstituted solution to minimise freeze-thaw cycles.